Les publications

Page en cours de mise à jour... Retrouvez ici les publications des équipes de recherche du CGO

376 publications
Année de publication :
Réseaux :

French Health Authority certification visit in a radiotherapy department.

The French Higher Health Authority’s (Haute Autorité de santé [HAS]) certification process is an important issue for a health care facility and in particular for a radiotherapy department. It is based on a quality-risk management methodology driven by the commitment and involvement of professionals.

  • Ref: Cancer Radiother. 2020 Oct;24(6-7):722-725.
  • Année de publication : 2020
  • Auteurs : Ponsard N, Heddadi L, Pradier O.
  • Réseaux : Réseaux: « Vectorisation, Imagerie, Radiothérapies »
Lire la publication

Fully automatic segmentation of diffuse large B cell lymphoma lesions on 3D FDG-PET/CT for total metabolic…

Purpose: Lymphoma lesion detection and segmentation on whole-body FDG-PET/CT are a challenging task because of the diversity of involved nodes, organs or physiological uptakes.

  • Ref: Eur J Nucl Med Mol Imaging. 2020 Oct 24.
  • Année de publication : 2020
  • Auteurs : Blanc-Durand P, Jégou S, Kanoun S, Berriolo-Riedinger A, Bodet-Milin C, Kraeber-Bodéré F, Carlier T, Le Gouill S, Casasnovas RO, Meignan M, Itti E.
  • Réseaux : Réseaux: « Vectorisation, Imagerie, Radiothérapies »
Lire la publication

Reply to the ‘Comment on “Investigation of Zr(iv) and 89Zr(iv) complexation with hydroxamates: progress towards designing…

The alternative analysis of A. Bianchi and M. Savastano is a valuable contribution to the understanding of the complex systems at stake in the complexation chemistry of Zr4+ by considering polynuclear species.

  • Ref: Chem Commun (Camb). 2020 Oct 25;56(83):12667-12668.
  • Année de publication : 2020
  • Auteurs : Guérard F, Lee YS, Tripier R, Szajek LP, Deschamps JR, Brechbiel MW.
  • Réseaux : Réseaux: « Vectorisation, Imagerie, Radiothérapies »
Lire la publication

Targeted-Alpha-Therapy Combining Astatine-211 and anti-CD138 Antibody in A Preclinical Syngeneic Mouse Model of Multiple Myeloma Minimal…

Despite therapeutic progress in recent years with the introduction of targeted therapies (daratumumab, elotuzumab), multiple myeloma remains an incurable cancer.

  • Ref: Cancers (Basel). 2020 Sep 22;12(9):2721.
  • Année de publication : 2020
  • Auteurs : Gouard S, Maurel C, Marionneau-Lambot S, Dansette D, Bailly C, Guérard F, Chouin N, Haddad F, Alliot C, Gaschet J, Eychenne R, Kraeber-Bodéré F, Chérel M.
  • Réseaux : Réseaux: « Vectorisation, Imagerie, Radiothérapies »
Lire la publication

Glucose Metabolism Quantified by SUVmax on Baseline FDG-PET/CT Predicts Survival in Newly Diagnosed Multiple Myeloma Patients.

Background: Multiple myeloma is a hematological neoplasm characterized by a clonal proliferation of malignant plasma cells in the bone marrow, and is associated with high morbidity and mortality and variable survival.

  • Ref: Cancers (Basel). 2020 Sep 6;12(9):2532.
  • Année de publication : 2020
  • Auteurs : Michaud-Robert AV, Zamagni E, Carlier T, Bailly C, Jamet B, Touzeau C, Moreau P, Kraeber-Bodere F, Nanni C, Bodet-Milin C.
  • Réseaux : Réseaux: « Vectorisation, Imagerie, Radiothérapies »
Lire la publication

Long-term Trace of Radiation Pneumonitis With 18F-Fluoroestradiol.

Radiation pneumonitis (RP) can be an adverse complication of radiotherapy and usually occurs as an acute reaction from 6 to 12 weeks after radiotherapy.

  • Ref: Clin Nucl Med. 2020 Sep;45(9):e403-e405.
  • Année de publication : 2020
  • Auteurs : Morel A, Maucherat B, Chiavassa S, Kraeber-Bodéré F, Rousseau C.
  • Réseaux : Réseaux: « Vectorisation, Imagerie, Radiothérapies »
Lire la publication

Treatment of radiation-induced late effects: What’s new?

Mechanisms of late radio-induced lesions are the result of multiple and complex phenomena, with many entangled cellular and tissue factors.

  • Ref: Cancer Radiother. 2020 Oct;24(6-7):602-611.
  • Année de publication : 2020
  • Auteurs : Chargari C, Supiot S, Hennequin C, Chapel A, Simon JM.
  • Réseaux : Réseaux: « Vectorisation, Imagerie, Radiothérapies »
Lire la publication

Osteosarcoma of the jaws: An overview of the pathophysiological mechanisms.

Osteosarcoma (OS) is the most common cancer of bone. Jaw osteosarcoma (JOS) is rare and it differs from long-bone OS (LBOS) in terms of the time of onset (two decades later), lower metastatic spread, and better survival.

  • Ref: Crit Rev Oncol Hematol. 2020 Oct 10;156:103126.
  • Année de publication : 2020
  • Auteurs : Bertin H, Gomez-Brouchet A, Rédini F.
  • Réseaux : Réseaux: « Vectorisation, Imagerie, Radiothérapies »
Lire la publication

Overview of Radiolabeled Somatostatin Analogs for Cancer Imaging and Therapy.

Identified in 1973, somatostatin (SST) is a cyclic hormone peptide with a short biological half-life. Somatostatin receptors (SSTRs) are widely expressed in the whole body, with five subtypes described.

  • Ref: Molecules. 2020 Sep 2;25(17):4012.
  • Année de publication : 2020
  • Auteurs : Eychenne R, Bouvry C, Bourgeois M, Loyer P, Benoist E, Lepareur N.
  • Réseaux : Réseaux: « Vectorisation, Imagerie, Radiothérapies »
Lire la publication

Random survival forest to predict transplant-eligible newly diagnosed multiple myeloma outcome including FDG-PET radiomics.

Purpose: Fluorodeoxyglucose-positron emission tomography/computed tomography (FDG-PET/CT) is included in the International Myeloma Working Group (IMWG) imaging guidelines for the work-up at diagnosis and the follow-up of multiple myeloma (MM) notably because it is a reliable tool as a predictor of prognosis.

  • Ref: Eur J Nucl Med Mol Imaging. 2020 Oct 2.
  • Année de publication : 2020
  • Auteurs : Jamet B, Morvan L, Nanni C, Michaud AV, Bailly C, Chauvie S, Moreau P, Touzeau C, Zamagni E, Bodet-Milin C, Kraeber-Bodéré F, Mateus D, Carlier T.
  • Réseaux : Réseaux: « Vectorisation, Imagerie, Radiothérapies »
Lire la publication